- Home
- / PMV Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PMV Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.6
2024-10-29
Market Capitalization
$85 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| General and administrative expense | 11.0M | 21.8M | 25.1M | 24.2M | 26.9M | 16.3M |
| Operating expense total | 34.9M | 58.3M | 77.0M | 80.1M | 85.4M | 86.2M |
| EBIT | (34.9M) | (58.3M) | (77.0M) | (80.1M) | (85.4M) | (86.2M) |
| Interest expense | 651.0K | 449.0K | 3.6M | 11.2M | 10.7M | 6.3M |
| Pre tax profit | (34.4M) | (57.8M) | (73.3M) | (69.0M) | (74.8M) | (79.9M) |
| Income tax expense | 6.0K | 23.0K | (9.0K) | 2.0K | (16.1M) | (2.2M) |
| Net Income | (34.4M) | (57.8M) | (73.3M) | (69.0M) | (58.7M) | (77.7M) |
| EPS | (1.6) | (1.4) | (1.1) | (1.5) |